Schedule 13G ownership disclosure

Sigyn Therapeutics, Inc.

Security class unavailable · CUSIP: 82674U106

Event date: 2021-01-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-21-004562
Form type
SC 13G/A
Filer
Brio Capital Master Fund Ltd.
CIK
CIK 1560894
Filed
Jan 27, 2021
Reporting period
Jan 17, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub